Evidence map›Paper›PMID 39409911›Full record

ArticleCancers2024

BUB1 Inhibition Overcomes Radio- and Chemoradiation Resistance in Lung Cancer.

Shivani Thoidingjam, Sushmitha Sriramulu, Oudai Hassan, Stephen L Brown, Farzan Siddiqui, Benjamin Movsas, Shirish Gadgeel, Shyam Nyati

Abstract read
In one paragraph

Article in Cancers, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Shivani ThoidingjamDepartment of Radiation Oncology, Henry Ford Health, Detroit, MI 48202, USA.
Sushmitha SriramuluDepartment of Radiation Oncology, Henry Ford Health, Detroit, MI 48202, USA.
Oudai HassanDepartment of Surgical Pathology, Henry Ford Cancer Institute, Henry Ford Health, Detroit, MI 48202, USA.
Stephen L BrownDepartment of Radiation Oncology, Henry Ford Health, Detroit, MI 48202, USA.
Farzan SiddiquiDepartment of Radiation Oncology, Henry Ford Health, Detroit, MI 48202, USA.
Benjamin MovsasDepartment of Radiation Oncology, Henry Ford Health, Detroit, MI 48202, USA.
Shirish GadgeelHenry Ford Health + Michigan State University Health Sciences, Detroit, MI 48202, USA.ORCID 0000-0001-5240-3811
Shyam NyatiDepartment of Radiation Oncology, Henry Ford Health, Detroit, MI 48202, USA.ORCID 0000-0002-1435-303X

Funding

Targeting BUB 1 for radio- and immuno-sensitization of Triple Negative Breast Cancer (TNBC)R21CA252010 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI GREEN, MICHAEL DANIEL, NYATI, SHYAM · 2021 to 2021
$401k
NIH HHS 1R21CA252010-01A1
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

BUB1chemoradiationchemotherapylung cancermolecular targetradiotherapy

Identifiers

PMID39409911
PMCPMC11475950

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.